Brief: Kane Biotech Announces Distribution Agreement With Progenacare Global For Its Coactiv+™ Antimicrobial Wound Gel
20/04/2023 12:31
April 20 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES DISTRIBUTION AGREEMENT WITH
PROGENACARE
GLOBAL FOR ITS COACTIV+™ ANTIMICROBIAL WOUND GEL
Source text for Eikon: ID:nGNX5yKVsS
Further company coverage: KNE.V
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update